Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
This study retrospectively analyzes patients with SMARCA4-deficient tumors, including advanced non-small cell lung cancer, to describe clini…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer [NA]
An update on the CT-STAR radiotherapy approach (Computed Tomography-Guided Stereotactic Adaptive Radiotherapy) being studied for central and…
-
CLINICAL_TRIALS withdrawal · 2025-08-13Clinical Trial Update: Expanded Access of Sotorasib
Expanded access program for sotorasib (Amgen) in non-small cell lung cancer is no longer available.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: A Study of GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation [Phase 1, Phase 2]
A Phase 1/2 study evaluating GFH925 in combination with cetuximab for previously untreated advanced non-small cell lung cancer with a KRAS G…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers [Phase 1]
Phase I clinical trial update for the radiopharmaceutical [68Ga]Ga-DWJ155 in patients with breast cancer and non-small cell lung cancer; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-08-12EMA Authorised: Naveruclif (paclitaxel) — Accord Healthcare S.L.U.
EMA authorised Naveruclif (paclitaxel) by Accord Healthcare S.L.U. for breast cancer, pancreatic cancer, and non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-927 in combination with ABBV-368, Budigal…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
Describes a planned clinical trial evaluating a perioperative comprehensive diagnosis and treatment system for lung cancer in the era of neo…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC [Phase 3]
Phase 3 trial of adjuvant durvalumab (MEDI4736) in completely resected non-small cell lung cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm [NA]
This ClinicalTrials.gov entry describes a recruiting study from Fudan University evaluating selective lymph node resection for invasive non-…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating the bioavailability of subcutaneously administered tislelizumab for first-line treatment of advanced or metastati…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update investigating CD8+ T cell imaging during treatment in patients with non-small cell lung cancer, currently recr…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer [Phase 1]
Phase 1 safety study evaluating enoblituzumab (MGA271) in combination with pembrolizumab or MGA012 in patients with refractory cancers. Resu…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC [Phase 2, Phase 3]
A head-to-head Phase 2/Phase 3 trial compares D-0316 to icotinib in locally advanced or metastatic non-small cell lung cancer with EGFR-sens…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC) [Phase 1]
Phase 1 study to evaluate the safety, tolerability, and efficacy of TMT101 injection as monotherapy in patients with advanced pancreatic can…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study
An exploratory observational study examining the relationships between inflammation, cachexia, and therapeutic response in non-small cell lu…
-
CLINICAL_TRIALS withdrawal · 2025-08-08Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases [Phase 2]
A Phase 2 trial of Datopotamab Deruxtecan (Dato-DXd) for non-small cell lung cancer with active brain metastases has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma
This update reports on survival outcomes for a combination of radiotherapy and immunotherapy in metastatic non-small cell lung cancer, with …
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Study to Evaluate CCS1477 in Advanced Tumours [Phase 1, Phase 2]
A Phase 1/2 study of CCS1477 has completed, evaluating it in metastatic castration-resistant prostate cancer and metastatic breast cancer, w…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: AI-Based Prediction of Stage and Survival in Non-Small Cell Lung Cancer: A Retrospective Study
This clinical trial update describes a retrospective study using AI to predict cancer stage and survival in non-small cell lung cancer. The …
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with bevacizumab for treatment of brain metastases in metastatic melanoma or non-small…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy [Phase 3]
Phase 3 trial evaluating ASKC202 in combination with Limertinib versus platinum-based chemotherapy for locally advanced or metastatic non-sm…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1, first-in-human dose-finding and expansion study of XmAb808 in combination with pembrolizumab in advanced solid tumors; the trial ha…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC [Phase 1]
Phase 1 randomized trial evaluating glutathione in combination with an anti-PD-1 antibody and chemotherapy for advanced non-small cell lung …